Clare E. Thomas
Impact in
- Genetics top 2%
- Virus-based gene therapy research
- Glioma Diagnosis and Treatment
- Molecular Biology top 5%
- RNA Interference and Gene Delivery
- CRISPR and Genetic Engineering
- Retinal Development and Disorders
Papers in
- Co-authors
- Mark A. Kay (4 shared papers)Anja Ehrhardt (1 shared paper)Pedro Ricardo Lowenstein (13 shared papers)Maria Graciela Castro (12 shared papers)Theresa A. Storm (3 shared papers)Zan Huang (1 shared paper)Gudrun Schiedner (2 shared papers)Stefan Kochanek (2 shared papers)
- Journals
- Nature Medicine (5 papers)Nature (3 papers)Journal of Virology (3 papers)Current Protocols in Neuroscience (2 papers)Gene Therapy (1 paper)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Clare E. Thomas
24 papers receiving 3.3k citations
Clare E. Thomas's Hit Papers
Peers
Comparison fields: 5 of 111
- Genetics 1.4k
- Molecular Biology 1.3k
- Biomaterials 175
- Genetics 113
- Virology 45
Countries citing papers authored by Clare E. Thomas
This map shows the geographic impact of Clare E. Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clare E. Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clare E. Thomas more than expected).
Fields of papers citing papers by Clare E. Thomas
This network shows the impact of papers produced by Clare E. Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clare E. Thomas. The network helps show where Clare E. Thomas may publish in the future.
Co-authors
The 25 scholars most cited alongside Clare E. Thomas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Progress and problems with the use of viral vectors for gene therapy Hit paper breakdown → | 2003 | 2131 |
| 2 | 2004 | 310 | |
| 3 | 2000 | 218 | |
| 4 | 2003 | 183 | |
| 5 | 2001 | 145 | |
| 6 | 2002 | 87 | |
| 7 | 2001 | 85 | |
| 8 | 2006 | 82 | |
| 9 | 2002 | 47 | |
| 10 | 2010 | 37 | |
| 11 | 2009 | 36 | |
| 12 | 2002 | 28 | |
| 13 | 2006 | 21 | |
| 14 | 2006 | 15 | |
| 15 | 2000 | 8 | |
| 16 | 2003 | 8 | |
| 17 | 1999 | 7 | |
| 18 | 1999 | 4 | |
| 19 | 2006 | 4 | |
| 20 | 2009 | 3 |
About Clare E. Thomas
Clare E. Thomas is a scholar working on Genetics, Virology, Immunology, Microbiology and Neurology, having authored 26 papers that have together received 3.5k indexed citations. Recurring topics across this work include Virus-based gene therapy research (16 papers), HIV Research and Treatment (2 papers), T-cell and B-cell Immunology (2 papers), Antimicrobial Peptides and Activities (1 paper), Material Selection and Properties (1 paper), RNA Research and Splicing (1 paper), Pharmaceutical Economics and Policy (1 paper) and Health and Medical Research Impacts (1 paper). The work is most often cited by research in Genetics (1.4k citations), Molecular Biology (1.3k citations), Biomaterials (175 citations), Genetics (113 citations) and Virology (45 citations). Clare E. Thomas has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Mark A. Kay, Anja Ehrhardt, Pedro Ricardo Lowenstein, Maria Graciela Castro, Theresa A. Storm, Zan Huang, Gudrun Schiedner, Stefan Kochanek, Sally Fuess and Hiroyuki Nakai. Their work appears in journals such as Nature Medicine, Nature, Journal of Virology, Current Protocols in Neuroscience and Gene Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.